Clinical Trials Browser

Lymphoma, B-Cell × Injections × 90 days × Clear all

NCT06565689 2026-02-05

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of YK012

Phase 1 Recruiting

Recurrence, Lymphoma, B-Cell